0000950123-18-001724.txt : 20180213
0000950123-18-001724.hdr.sgml : 20180213
20180213132534
ACCESSION NUMBER: 0000950123-18-001724
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20180213
DATE AS OF CHANGE: 20180213
EFFECTIVENESS DATE: 20180213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRV GP II, LLC
CENTRAL INDEX KEY: 0001614073
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18419
FILM NUMBER: 18601713
BUSINESS ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001614073
XXXXXXXX
12-31-2017
12-31-2017
TRV GP II, LLC
THIRD ROCK VENTURES
29 NEWBURY STREET, 3RD FLOOR
BOSTON
MA
02116
13F HOLDINGS REPORT
028-18419
N
Kevin Gillis
Chief Financial Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
02-13-2018
3
5
555262
false
1
Mark Levin
2
Kevin P. Starr
3
Robert I. Tepper
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
SAGE THERAPEUTICS, INC.
COM
78667J108
90247
547916
SH
DFND
1,2,3
547916
0
0
JOUNCE THERAPEUTICS, INC.
COM
481116101
130437
10230349
SH
DFND
1,2,3
10230349
0
0
MYOKARDIA, INC.
COM
62857M105
121463
2885104
SH
DFND
1,2,3
2885104
0
0
BLUEPRINT MEDICINES CORPORATION
COM
09627Y109
185038
2453753
SH
DFND
1,2,3
2453753
0
0
ALLENA PHARMACEUTICALS, INC.
COM
018119107
28077
2790964
SH
DFND
1,2,3
2790964
0
0